Use of 5α-reductase inhibitor and delay in prostate cancer diagnosis and treatment

Int Braz J Urol. 2020 May-Jun;46(3):456-458. doi: 10.1590/S1677-5538.IBJU.2020.03.02.
No abstract available

Publication types

  • Editorial

MeSH terms

  • 5-alpha Reductase Inhibitors / therapeutic use*
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Male
  • Oxidoreductases
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism

Substances

  • 5-alpha Reductase Inhibitors
  • Enzyme Inhibitors
  • Oxidoreductases